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Introduction
Thiol-disulfide metabolism is a factor, which largely de-
termines the functional activity of human body. Its inten-
sity conditions the speed of the most diverse reactions of 
biosynthesis, growth and development of cells and organs, 
transport and repair processes and many other aspects of 
vital activity. This explains the constant interest of scientists 
in the exploring of various aspects of thiol-disulfide meta-
bolism [1-3].
A very topical issue is the need to study the new coor-
dination compounds of transition metals, especially the 
thiosemicarbazon derivatives, which can serve as a basis in 
the development of the medicinal preparations for the pro-
phylaxis and the treatment of various diseases, including the 
renal ones and the stimulation of the regenerative processes 
in the tissues. Many medicinal remedies that contain met-
als exhibit modulatory effects on the thiol-disulfide system, 
which provides an opportunity to understand the molecu-
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Abstract
Background: Thiol-disulfide metabolism is essential for normal function of the organism. Thus the interest of the scientists in this area of research 
continues to grow.
Material and methods: Copper coordination compounds (CCC), derivatives of thiosemicarbaside (CMD-4, CMJ-33, CMT-67), action on thiol-disulfide 
metabolism in the healthy Ratta albicans kidneys were studied. The animals were divided in 6 groups of 7 rats each. The control group included healthy 
rats which were injected i/m physiological solution 3 times a week, for 30 days. The rats from groups 2-6 have got 3 times a week, for 30 days, i/m 
injections of CCC. The activity of following thiol-disulfide metabolism enzymes in the renal supernatant has been measured: glutathion-reductase (GR), 
glutathion-peroxidase (GPO), glutathion-S-transferase (G-S-T), γ-glutamyl transpeptidase (γ-GTP), glutaredoxin (Grx), as well the amount of the protein 
SH-groups and of the total glutathione, reduced glutathione (GSH) and oxidized glutathione (GSSG) in renal tissue.
results: The compounds exhibit different actions: CMT-67 in the dose of 0.1 µM/kg influenced the activity of the glutathione metabolism enzymes – 
activated γ-glutamyl transpeptidase (γ-GTP) and glutaredoxine (Grx) and inhibited glutathione reductase (GR), while CMD-4 in doses of 0.1 µM/kg 
and 1.0 µM/kg and CMJ-33 in the dose of 1.0 µM/kg significantly diminished the reduced glutathione (GSH) level and increased the amount of the 
oxidised one (GSSG).
Conclusions: Selective action of the copper coordination copounds established by this study opens new possibilities of their usage in the therapy of 
kidney diseases.
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lar mechanisms of their action on the body and allow the 
development of new strategies for the treating of different 
diseases [4]. 
Due to their high biological activity, especially, to in-
fluence the thiol redox system, the thiosemicarbazon de-
rivatives are increasingly used for the treatment of various 
diseases, including cancer [5]. The performed preliminary 
researches have revealed their therapeutic efficacy and the 
prospects for using of these compounds [6].
In the scientific studies with reference to the problem in 
question, the data that reveal the changes of thiol-disulfide 
metabolism in the renal tissue in the use of new thiosemi-
carbazon derivatives, complexed with metal ions are lacking.
The aim of the study was to elucidate the peculiarities of 
thiol-disulfide metabolism and its pathogenic importance 
in the renal tissue of laboratory healthy animals while ad-
ministering of some new copper coordination compounds 
(CCC), derivatives of thiosemicarbazide.
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Material and methods
The new local CMD-4, CMJ-33 and CMT-67 copper 
coordinative compounds, derivatives of the thiosemicarba-
zide, synthesized in the Laboratory of Advanced Materials 
in Biopharmacy and Technique of the State University of 
Moldova, have been studied [6-8]. 
Experiments have been performed on white labora-
tory rats (No 42) weighting 180-240 g. The research pro-
tocol was approved by the Research Ethic Board of Nicolae 
Testemitanu State University of Medicine and Pharmacy 
(No 43 of June 18, 2015) and the tests have been done ac-
cording to the contemporary principles in biological stan-
dardization of experiences and Declaration of Helsinki with 
further amendments (Somerset West Amendment, 1996). 
The animals have been randomly divided in 6 groups of 
7 rats each, with chow and water available ad libitum. The 
control group included healthy rats which were injected i/m 
physiological solution 3 times a week, for 30 days. The rats 
from groups 2-6 have got 3 times a week, for 30 days, i/m 
injections of copper coordination compounds as following: 
group 2 – CMD-4 (0.1 µM/kg), group 3 – CMD-4 (1.0 µM/
kg), group 4 – CMJ-33 (0.1 µM/kg), group 5 – CMJ-33 (1.0 
µM/kg) and group 6 – CMT-67 (0.1 µM/kg). The experi-
mental animals have been euthanized 24 hours after the last 
administration of CCC and the kideys have been removed.
The kidneys have been homogenized in 0.1 M (pH 7.4) 
phosphate buffer solution that contained 1 mM EDTA, final 
dilution 1:10. Membranes have been destroyed by Triton 
X-100 processing (final concentration 0.1%). All proce-
dures have been performed in glacial media. The obtained 
homogenate has been subjected to centrifugation for 15 min 
at 5000 rotations per minute and the supernatant has been 
stored at (-) 40°C.
The activity of following thiol-disulfide metabolism 
enzymes in the renal supernatant has been measured: 
glutathion-reductase (GR), glutathion-peroxidase (GPO), 
glutathion-S-transferase (G-S-T), γ-glutamyl transpepti-
dase (γ-GTP), glutaredoxin (Grx), as well the amount of 
the protein SH-groups and of the total glutathione, reduced 
glutathione (GSH) and oxidized glutathione (GSSG) in re-
nal tissue. Spectrophotometric micromethods adapted for 
Synergy H1 Hybrid Rider (BioTek Instruments, USA) have 
been applied [9, 10].
Data were subjected to statistical analysis in StatsDirect 
Statistical Software (version 1.9.5., 2001) using U Mann-
Whitney non-parametric test to determine the differences 
between means at the significant level of p<0.05.
Results
Table 1 shows the activities of the thiol-disulfide metab-
olism enzymes (GR, GPO, G-S-T, γ-GTP and Grx) in the 
kidney homogenate after the administration of the CCC. 
The data reveals that the CCC exhibit different action upon 
the studied glutathione-dependent enzymes activities in the 
kidneys. The GR and G-S-T activities decreased by 14-35%, 
while GPO – non-significantly, under the influence of all 
studied compounds.  γ-GTP was inhibited by CMJ-33 ad-
ministrated in dose of 1.0 µM/kg, while the rest of the CCC 
have not changed the activity of the enzyme in comparison 
with the control group. Compound CMD-4 in both doses 
has not induced significant changes of Grx activity, which 
was considerably increased (up to 39-95%) by both doses of 
CMJ-33 and CMT-67 in the dose of 0.1 µM/kg.
The research results of the influence of studied com-
pounds on the level of total, reduced and oxidized glutathi-
one and protein SH groups in the kidney tissue are presented 
in table 2. Studied compounds have not induced statistically 
significant changes of the total glutathione level in the kid-
neys. Administration of both doses of CMD-4 and CMJ-33 
in the dose of 1.0 µM/kg has produced a significant decrease 
(by 75-86%) of GSH along with a considerable increase of 
GSSG level – more than 2 times in comparison with the 
control group. Subsequently the GSH/GSSG ratio was no-
tably reduced. The amount of protein SH groups manifested 
a decreasing tendency by the studied CCC, but the attested 
decrease has proved to be of no statistical relevance.
Discussion
The influence of CCC on the thiol-disulfide metabolism 
in the kidneys of healthy rats has been studied. GPO, G-S-T, 
GR, γ-GTP, Grx and reduced glutathion (GSH) are the ele-
ments of a complex antioxidant system that neutralizes the 
hydrogen peroxide and organic peroxides both in the cellular 
environments and biological membranes. Organic peroxides 
having a high damaging capacity can induce a series of chain 
reactions that will deteriorate the cellular structures [11]. 
We have identified a statistic significant decrease of the 
GR and G-S-T activities after the administration of the min-
imal dose of CCC (0.1 µM/kg), while the high dose (1 µM/
kg) has not produced a significant effect on the enzymes ac-
tivity (p>0.05). 
The biological role of GR is to maintain a high level of 
GSH and low one of GSSG, which is particularly important, 
because glutathion performs its biological functions only in 
the reduced form. GR, having high activity in the kidneys, 
represents the enzyme that reduces GSSG and thus plays 
a cardinal role in the GSH recycling. We have attested the 
reduction of the GR activity in the kidneys after the admin-
istration of low doses of CCC, thus the enzyme can not re-
store the GSH level by reducing GSSG. The inability of GR 
to reduce GSSG and maintain the optimal level of GSH will 
disturb the proper functions of GPO and GST, that require 
GSH for peroxides reduction, and/or of Grx, that reduces 
the disulfides [11-13]. Thus, the CCC, diminishing the ac-
tivity of GR, can influence the activities of GPO, G-S-T and 
Grx through the reduction of GSH amount in the kidneys.
Our study revealed a significant decrease of the G-S-T 
activity in the kidneys after CCC administration. In the 
kideys G-S-Ts are expressed in the tubules and acount for 
2% of the total soluble cytoplasmic proteins. Recently was 
established that G-S-Ts are involved in the metabolism of 
xenobiotics and can neutralize the final products of lipid 
13
14
ORIGINAL  ReseARchV. Sardari et al. Moldovan Medical Journal. June 2020;63(2):12-17
peroxidation – a,b-highly reactive unsaturated aldehydes, 
such as 4-hydroxynonenal (4-HNE), and the latter com-
pound, via a feedback mechanism, is involved in the regula-
tion of the multiple cell signaling pathways.
The pronounced inhibition of GST activity in the renal 
tissue, detected in our research, may induce the increase of 
4-HNE concentration, which in turn causes inhibition of 
pro-proliferative mechanisms, as well as DNA and protein 
synthesis, which may result in apoptotic or necrotic even-
tual death of cells [14]. Thus, inhibition of GSTs at the cel-
lular level, along with other mechanisms, could underlie the 
antiproliferative, antitumor properties of these compounds 
and, it is not excluded, could produce effects, manifested 
also by a certain degree of nephrotoxicity. Participation of 
G-S-Ts as mediators of the signaling pathways involved in 
cell proliferation and death have been highlighted by nu-
merous previous studies [15-17]. In other words, GSTs reg-
ulate cellular homeostasis by modulating intracellular levels 
of 4-HNE, and the latter functions as a sensor that at low 
concentrations directs cells to proliferation, survival, differ-
entiation, and at increased concentrations causes inhibition 
of pro-proliferative processes, which induces apoptosis and 
necrosis [18, 19].
Therefore, G-S-T activity can be an important tissue 
marker of the effects on cell signaling, but also of the mech-
anisms underlying toxic/side effects of the chemical com-
pounds tested as new pharmaceutical remedies.
GPO is a family of antioxidant enzymes, present in the 
tissues under several isoenzymes. The kidney isoform – 
GPO-3, is a tetrameric selenoprotein that is attached to the 
basal membrane of the proximal renal tubes. The GPO-3 
is responsible for the reduction of hydrogen peroxide and 
of some organic peroxides using GSH as a donor of reduc-
ing equivalents. The GPO activity was not significantly 
decreased by the administration of CCC and the ability to 
reduce H2O2 to water and the potential for annihilation of 
organic peroxides was preservered, thereby the kindey cells 
were protected from oxidative damage.
The kidney is the main organ that regulates the plasma 
level of GSH, due to the high activity of γ-GTP in the re-
nal convoluted tubules [20]. The enzyme is essental in the 
γ-glutamyl cycle, a pathway responsible for amino acids 
and peptides transfer through membranes into the cell, as 
well as in protein synthesis, synthesis and cleavage of glu-
tathione, detoxification of medicines and xenobiotics [11, 
13, 21, 22]. γ-GTP may also exhibit prooxidative properties 
in some circumstance and induce metal-dependent DNA 
damage [23-25].
Studied CCC maintained the γ-GTP activity at the level 
specific for control group animals that proves that the CCC 
do not influence the γ-GTP-dependent processes men-
tioned above. As an exception a significant decrease was re-
vealed after the administration of CMJ-33 in maximal dose 
of 1.0 µM/kg. 
This fact, probably, not only affects the translocation of 
amino acids and proteosynthetic processes in the renal cell, 
but can also be regarded as a process oriented to the reduc-
ing of the oxidative damage of cellular DNA dependent on 
metal ions, such as Fe, Cu, etc. In the literature it has been 
reported that γ-GTP may also exhibit prooxidative proper-
ties in some circumstance and in the presence of metal ions, 
such as Fe2+, Cu+, increases the level of DNA damage and ni-
trogenous bases [24, 25]. Subsequently CMJ-33 is not only 
having an impact on the amino acids transfer into the cell 
and protein synthesis in the kidneys, but also can prevent 
the oxidative damage of the DNA from metal ions like Fe2+, 
Cu+, etc. 
Thus, the tissue level of γ-GTP activity can be an impor-
tant marker of protein synthesis and DNA metal-ion depen-
dent damage in preclinical and clinical studies of potential 
medicines, as long in the research of pathogenic mechanism 
of kidney diseases. 
Grx was activated by CMJ-33 and CMT-67 revealing 
the capacity of these compounds to induce the reactions of 
reduction/deglutathionilation of proteins. Such reactions 
are catalysed by glutaredoxines/thioltransferases (Grx/TT) 
‒ members of the GSH-dependent thioldisulfide oxidore-
ductases, involved in reduction of disulfides or GSH mixed 
disulfides [26-28]. Grx and thioredoxin are catalyzing the 
reduction of protein disulfides, sulfoxides and sulfenic acid, 
as well as the reduction of ribose in the pathway of deoxy-
ribonucleotide synthesis [29]. It is known that GSH modu-
lates the DNA synthesis by maintaining glutaredoxin and/or 
thioredoxin in a reduced state, which is required for the ac-
tivity of ribonucleotide reductase, enzyme that limits DNA 
synthesis in the cells [30].
Grx regulates through redox mechanisms the nuclear 
kB factor (NF-kB) expression and subsequently the che-
mokine production and inflammation in the kidneys [31]. 
Also these mechanisms involve Grx in the regulation of the 
eneregy state of the kidneys [32].  Therefore, Grx can be a 
valuable tissue marker, not only for assessing the detailed 
mechanisms of action of various chemical compounds test-
ed as new therapeutic agents in vivo, but also for an in-depth 
study of the pathogenesis of kidney diseases.
The changes of GSH and GSSG amounts, as long of the 
GSH/GSSG ratio have been studied in the kidneys after ad-
ministration of the CCC in different doses. The statistic sig-
nificant decrease of GSH, increase of GSSG and decline of 
the GSH/GSSG ratio have been revealed in our study. Those 
changes can be a consequence of the reduction of the GSH 
recycling rate at enzyme level or/and enhancement of GSSG 
formation due to oxidative stress exacerbation.
The optimal GSH/GSSG ratio is important for cell vi-
tality, and alteration of the intracellular GSH balance has 
been reported in many diseases, including tumors [33, 34]. 
Abnormal GSH/GSSG ratio can trigger significant changes 
of the redox-dependent cellular signaling mechanisms that 
are involving G-S-T and Grx. 
Likewise, it is important to note that shifting the GSH/
GSSG redox toward the oxidizing state activates several sig-
naling pathways, like nuclear factor κB, c-Jun N-terminal 
kinase, apoptosis signal-regulated kinase 1, protein kinase 
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B, protein phosphatases, etc., thereby reducing cell prolif-
eration and increasing apoptosis [35].
It is known that reduced glutathion plays an important 
role in antioxidant protection and is involved in regulation 
of major cellular processes like gene expression, protein syn-
thesis, apoptosis, signal transduction, cytokine production 
and immune response and glutathionylation of proteins  [2, 
27, 33, 34, 36]. In reduced form, this tripeptide is involved 
in many reactions and processes, due to the high reactiv-
ity of the SH group, which by giving an electron pair can 
achieve a wide range of reversible or irreversible chemical 
combinations. GSH can directly or through some enzymatic 
reactions, acting as a coenzyme of GPO or GST, efficiently 
capture free radicals and other reactive oxygen species and 
neutralize endogenous or/and exogenous toxic compounds 
[20, 37, 38]. Thus, its decrease can have a significant impact 
on the mentioned processes.
The overall changes of the thiol-disulfide metabolism in 
the kidneys after the administration of the CCC offer new 
incites on this metabolic branch role in tissue homeosta-
sis and possibilities of CCC usage in the treatment of the 
kidney diseases, as well as new directions of research of the 
therapeutical and preventive potential of the novel copper 
coordination compounds derivatives of thiosemicarbazide 
in kidney diseases.
Conclusions
1.  The main indices of thiol-disulfide metabolism that 
can reveal the efficiency of the novel copper coordination 
compounds derivatives of thiosemicarbazide, in the kidneys 
of healthy animals have been estimated. 
2. Evaluation of the activities of the thiol-disulfide me-
tabolism enzymes in the kidney homogenate after the ad-
Table 1 
The influence of copper coordination compounds derivatives of the thiosemicarbazide – CMD-4, 


















































































 Note: * – statistically significant difference with the control group, p <0.05; ** – p <0.01; *** – p <0.001.
Table 2
The influence of copper coordination compounds derivatives of the thiosemicarbazide – CMD-4, 
CMJ-33 and CMT-67 on the indices of thiol-disulfide metabolism in the kidney tissue of rats















































































 Note: * – statistically significant difference with the control group, p <0.05; ** – p <0.01; *** – p <0.001.
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ministration of the CCC revealed that GR and GST activi-
ties were inhibited by CMD-4, CMJ-33 and CMT-67 (0.1 
µM/kg), γ-GTP  –  by CMJ-33 (1.0 µM/kg), Grx activity was 
considerably increased by CMJ-33 (both doses) and CMT-
67 (0.1 µM/kg), while GPO function did not change.
3. CMD-4 (both doses) and CMJ-33 (1.0 µM/kg) in-
duced a significant increase of GSSG along with a consider-
able decrease of GSH and of the GSH/GSSG ratio. 
4. The study of the copper coordination compounds de-
rivatives of the thiosemicarbazide – CMD-4, CMJ-33 and 
CMT-67 influence on the thiol-disulfide metabolism, opens 
new possibilities of research with focus on the elucidation 
and analysis of the mechanism of CCC preventive and ther-
apeutical action in health and disease.
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